Status:
COMPLETED
Molecular Biology of Anal Cancer in HIV-Positive Patients
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
University of Lausanne Hospitals
University of Zurich
Conditions:
Carcinoma
HIV Infections
Eligibility:
All Genders
20-80 years
Brief Summary
The molecular mechanisms involved in squamous cell carcinoma of the anus (SCCA) are poorly elucidated. HIV-positive and renal transplant patients are at high risk for developing SCCA, indicating that ...
Detailed Description
Background: In the highly active antiretroviral therapy (HAART) era, the incidence of many cancers remains higher in the HIV-positive than in the general population. This is not only true for AIDS-de...
Eligibility Criteria
Inclusion
- Biopsy proven Squamous cell carcinoma of the anus
- Informed consent
Exclusion
- None
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00952874
Start Date
July 1 2009
End Date
June 1 2010
Last Update
June 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Geneva
Geneva, Switzerland, 1211